Role of Iron Deficiency in Heart Failure-Clinical and Treatment Approach: An Overview.
Cristina Elena SingerCorina Maria VasileMihaela PopescuAlin Iulian Silviu PopescuIulia Cristina MargineanGeorge Alexandru IacobMihai Daniel PopescuCristina Maria MargineanPublished in: Diagnostics (Basel, Switzerland) (2023)
Anemia is frequently encountered in CHF and represents a negative prognostic factor. Data from randomized controlled trials have underlined the administration of intravenous iron therapy (ferric carboxymaltose) as the only viable treatment option, with beneficial effects on quality of life and exercise capacity in patients with ID and systolic heart failure.
Keyphrases
- iron deficiency
- heart failure
- prognostic factors
- randomized controlled trial
- left ventricular
- blood pressure
- clinical trial
- chronic kidney disease
- stem cells
- electronic health record
- combination therapy
- cardiac resynchronization therapy
- high intensity
- body composition
- machine learning
- big data
- study protocol
- artificial intelligence